{
    "Variants Include": [
        {
            "Gene": "PARK2",
            "variants": [
                {
                    "HGVS": "NM_004562.3:c.823C>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "823"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "W",
                        "position": "275"
                    },
                    "Description in input context": "Arg275Trp (R275W)"
                },
                {
                    "HGVS": "NM_004562.3:c.1253G>A",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "1253"
                    },
                    "Protein Change": {
                        "ref": "C",
                        "alt": "R",
                        "position": "418"
                    },
                    "Description in input context": "C418R"
                },
                {
                    "HGVS": "NM_004562.3:c.1321T>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "T",
                        "alt": "C",
                        "position": "1321"
                    },
                    "Protein Change": {
                        "ref": "C",
                        "alt": "R",
                        "position": "441"
                    },
                    "Description in input context": "C441R"
                },
                {
                    "HGVS": "NM_004562.3:c.482A>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "A",
                        "alt": "T",
                        "position": "482"
                    },
                    "Protein Change": {
                        "ref": "K",
                        "alt": "N",
                        "position": "161"
                    },
                    "Description in input context": "K161N"
                },
                {
                    "HGVS": "NM_004562.3:c.766C>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "766"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "C",
                        "position": "256"
                    },
                    "Description in input context": "R256C"
                },
                {
                    "HGVS": "NM_004562.3:c.124C>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "124"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "P",
                        "position": "42"
                    },
                    "Description in input context": "R42P"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Autosomal Recessive Juvenile Parkinson's Disease",
        "MONDO": "MONDO:0007748"
    },
    "Experiment Method": [
        {
            "Assay Method": "Caspase-3 Activity Measurement",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "TSM1 neurons, SH-SY5Y cells, Fibroblasts",
                "Description": "Cells were grown in 6-well plates and incubated with staurosporine or 6-OHDA."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.823C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "Mutation associated with familial Parkinson's disease abolishes parkin's protective effect against 6-OHDA-induced caspase-3 activation."
                },
                {
                    "Variant": "NM_004562.3:c.1253G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "C418R mutation abolishes parkin's ability to reduce 6-OHDA-stimulated caspase-3 activity."
                },
                {
                    "Variant": "NM_004562.3:c.1321T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "C441R mutation abolishes parkin's ability to reduce 6-OHDA-stimulated caspase-3 activity."
                },
                {
                    "Variant": "NM_004562.3:c.482A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "K161N mutation abolishes parkin's ability to reduce 6-OHDA-stimulated caspase-3 activity."
                },
                {
                    "Variant": "NM_004562.3:c.766C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "R256C mutation abolishes parkin's ability to reduce 6-OHDA-stimulated caspase-3 activity."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "R42P mutation abolishes parkin-induced reduction of p53 expression."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Bars represent the mean Â± s.e.m. of 3-5 independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Experiments performed in duplicate or triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type parkin used as a positive control for protective effect against caspase-3 activation."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector used as a negative control in transfection experiments."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Statistical analysis was performed with PRISM software using t-test Student or Newmann-Keuls multiple comparison tests for one-way analysis of variance."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Significant reduction in caspase-3 activity compared to mock-transfected cells (e.g., >40% reduction).",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "No significant reduction in caspase-3 activity compared to mock-transfected cells.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Western Blot Analysis",
            "Material used": {
                "Material Source": "Cell line and Tissue",
                "Material Name": "TSM1 neurons, SH-SY5Y cells, Fibroblasts, Human and Mouse Brain Tissue",
                "Description": "Proteins were separated on 12% SDS-PAGE gels and wet-transferred to Hybond-C membranes for immunoblotting."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.823C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "Increased p53 expression in AR-JP brains with R275W mutation."
                },
                {
                    "Variant": "NM_004562.3:c.1253G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "C418R mutation abolishes parkin's ability to reduce p53 expression."
                },
                {
                    "Variant": "NM_004562.3:c.1321T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "C441R mutation abolishes parkin's ability to reduce p53 expression."
                },
                {
                    "Variant": "NM_004562.3:c.482A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "K161N mutation abolishes parkin's ability to reduce p53 expression."
                },
                {
                    "Variant": "NM_004562.3:c.766C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "R256C mutation abolishes parkin's ability to reduce p53 expression."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "R42P mutation abolishes parkin-induced reduction of p53 expression."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments performed in duplicate or triplicate across multiple samples."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type parkin used as a positive control for p53 expression reduction."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector or mock-transfected cells used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Densitometric analysis normalized to actin expression, statistical significance determined by t-test or ANOVA."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "p53 expression levels comparable to wild-type parkin transfected cells (e.g., >50% reduction compared to control).",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "p53 expression levels significantly higher than wild-type parkin transfected cells (e.g., <50% reduction or increase compared to control).",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Chromatin Immunoprecipitation (ChIP) Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293 cells, Fibroblasts",
                "Description": "Cells were fixed with formaldehyde and processed for chromatin preparation."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.823C>T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Specific effect of R275W mutation on parkin-p53 promoter interaction not described in the literature."
                },
                {
                    "Variant": "NM_004562.3:c.1253G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "C418R mutation markedly reduces parkin binding to the p53 promoter."
                },
                {
                    "Variant": "NM_004562.3:c.1321T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "C441R mutation markedly reduces parkin binding to the p53 promoter."
                },
                {
                    "Variant": "NM_004562.3:c.482A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "K161N mutation markedly reduces parkin binding to the p53 promoter."
                },
                {
                    "Variant": "NM_004562.3:c.766C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "R256C mutation markedly reduces parkin binding to the p53 promoter."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Specific effect of R42P mutation on parkin-p53 promoter interaction not described in the literature."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type parkin used as a positive control for binding to p53 promoter."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Non-correlated antibodies (IgG control) or RNA pol IgG used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Detection of PCR amplification product indicating parkin binding to p53 promoter.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Lack of or reduced PCR amplification product indicating reduced or no parkin binding to p53 promoter.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}